Segall Bryant & Hamill, LLC Chroma Dex Corp. Transaction History

Segall Bryant & Hamill, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$3.0 - $5.52 $52,500 - $96,599	-17,500 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.54 - $4.75 $5,080 - $9,500	2,000 Added 12.9%	17,500 $57,000
Q4 2019 Feb 11, 2020	SELL	$2.83 - $4.61 $15,565 - $25,355	-5,500 Reduced 26.19%	15,500 $66,000
Q2 2019 Aug 14, 2019	BUY	$3.71 - $4.83 $3,710 - $4,830	1,000 Added 5.0%	21,000 $0
Q1 2019 May 15, 2019	SELL	$3.2 - $4.19 $6,400 - $8,380	-2,000 Reduced 9.09%	20,000 $0
Q3 2018 Nov 14, 2018	SELL	$3.5 - $4.91 $10,500 - $14,730	-3,000 Reduced 12.0%	22,000 $0
Q4 2017 Feb 15, 2018	SELL	$3.88 - $6.96 $19,400 - $34,800	-5,000 Reduced 16.67%	25,000 $0
Q3 2017 Nov 14, 2017	BUY	$2.91 - $4.71 $87,300 - $141,300	30,000	30,000 $0

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $510M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.